BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35871905)

  • 1. Current medical treatment and perspective in gonadotroph tumors.
    Even-Zohar N; Greenman Y
    Best Pract Res Clin Endocrinol Metab; 2022 Dec; 36(6):101685. PubMed ID: 35871905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gonadotroph pituitary adenomas].
    Chanson P
    Ann Endocrinol (Paris); 2000 Sep; 61(3):258-68. PubMed ID: 10970952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotroph adenoma with secondary hypersecretion of testosterone.
    Chamoun R; Layfield L; Couldwell WT
    World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A silent follicle-stimulating hormone-producing pituitary adenoma in a teenage male.
    Tamiya H; Fukuhara N; Yoshida N; Suzuki H; Takeshita A; Inoshita N; Nishioka H; Takeuchi Y; Sano T; Yamada S
    Endocr Pathol; 2011 Dec; 22(4):212-7. PubMed ID: 21853289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
    Dai C; Liang S; Sun B; Kang J
    Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical therapy for gonadotroph and thyrotroph tumors.
    Shomali ME; Katznelson L
    Endocrinol Metab Clin North Am; 1999 Mar; 28(1):223-40, viii. PubMed ID: 10207693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Options for Gonadotroph Tumors: Current State and Perspectives.
    Ilie MD; Raverot G
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32735647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotroph cell adenomas of the pituitary.
    Snyder PJ
    Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
    Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
    World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically nonfunctioning pituitary adenomas.
    Snyder PJ
    Endocrinol Metab Clin North Am; 1993 Mar; 22(1):163-75. PubMed ID: 8449186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-functioning pituitary adenomas.
    Chanson P; Brochier S
    J Endocrinol Invest; 2005; 28(11 Suppl International):93-9. PubMed ID: 16625856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory nonfunctioning pituitary adenomas.
    Kolitz T; Greenman Y
    Pituitary; 2023 Jun; 26(3):278-280. PubMed ID: 36786972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of NFAs: medical treatment.
    Even-Zohar N; Greenman Y
    Pituitary; 2018 Apr; 21(2):168-175. PubMed ID: 29344905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent (clinically nonfunctioning) pituitary adenomas.
    Mayson SE; Snyder PJ
    J Neurooncol; 2014 May; 117(3):429-36. PubMed ID: 24676675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cabergoline modulation of alpha-subunits and FSH secretion in a gonadotroph adenoma.
    Giusti M; Bocca L; Florio T; Foppiani L; Corsaro A; Auriati L; Spaziante R; Schettini G; Giordano G
    J Endocrinol Invest; 2000; 23(7):463-6. PubMed ID: 11005271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects.
    Mercado M; Melgar V; Salame L; Cuenca D
    Endocrinol Diabetes Nutr; 2017; 64(7):384-395. PubMed ID: 28745610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Treatment of Pituitary Adenomas: A Review.
    Molitch ME
    JAMA; 2017 Feb; 317(5):516-524. PubMed ID: 28170483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.